OBJECTIVE: Allergic sensitization is very prevalent and often precedes the development of allergic disease. This study examined the association of race with allergic sensitization among healthy children with no family history of atopy. STUDY DESIGN: Two hundred seventy-five children, predominantly from lower socioeconomic strata, from Cincinnati, Ohio, ages 2 to 18 years without a family or personal history of allergic diseases, underwent skin prick testing to 11 allergen panels. The Pediatric Allergic Disease Quality of Life Questionnaire (PADQLQ) was used to examine the impact of sensitization on quality of life. RESULTS: Thirty-nine percent of healthy children were sensitized to 1 or more allergen panels. Multivariate logistic regression showed increased risk among African-American children for any sensitization (OR, 2.17; [95% CI: 1.23, 3.84]) and sensitization to any outdoor allergen (OR, 2.96 [95% CI: 1.52, 5.74]). Eighty-six percent of children had PADQLQ scores of 1 or less (0 to 6 scale). CONCLUSIONS: Allergic sensitization is prevalent even among children who do not have a personal or family history of asthma, allergic rhinitis, or atopic dermatitis and who have no evidence of current, even subtle effects from this sensitization on allergic disease-related quality of life. African-American children are at greater risk for presence of sensitization, especially to outdoor allergens.
OBJECTIVE:Allergic sensitization is very prevalent and often precedes the development of allergic disease. This study examined the association of race with allergic sensitization among healthy children with no family history of atopy. STUDY DESIGN: Two hundred seventy-five children, predominantly from lower socioeconomic strata, from Cincinnati, Ohio, ages 2 to 18 years without a family or personal history of allergic diseases, underwent skin prick testing to 11 allergen panels. The Pediatric Allergic Disease Quality of Life Questionnaire (PADQLQ) was used to examine the impact of sensitization on quality of life. RESULTS: Thirty-nine percent of healthy children were sensitized to 1 or more allergen panels. Multivariate logistic regression showed increased risk among African-American children for any sensitization (OR, 2.17; [95% CI: 1.23, 3.84]) and sensitization to any outdoor allergen (OR, 2.96 [95% CI: 1.52, 5.74]). Eighty-six percent of children had PADQLQ scores of 1 or less (0 to 6 scale). CONCLUSIONS:Allergic sensitization is prevalent even among children who do not have a personal or family history of asthma, allergic rhinitis, or atopic dermatitis and who have no evidence of current, even subtle effects from this sensitization on allergic disease-related quality of life. African-American children are at greater risk for presence of sensitization, especially to outdoor allergens.
Authors: L A Stevenson; P J Gergen; D R Hoover; D Rosenstreich; D M Mannino; T D Matte Journal: J Allergy Clin Immunol Date: 2001-11 Impact factor: 10.793
Authors: L A Lester; S S Rich; M N Blumenthal; A Togias; S Murphy; F Malveaux; M E Miller; G M Dunston; J Solway; R L Wolf; J M Samet; D G Marsh; D A Meyers; C Ober; E R Bleecker Journal: J Allergy Clin Immunol Date: 2001-09 Impact factor: 10.793
Authors: Haejin Kim; Linda Levin; Grace K LeMasters; Manuel Villareal; Sherry Evans; James E Lockey; Gurjit K Khurana Hershey; David I Bernstein Journal: Ann Allergy Asthma Immunol Date: 2012-02-28 Impact factor: 6.347
Authors: Melinda Butsch Kovacic; Jocelyn M Biagini Myers; Mark Lindsey; Tia Patterson; Sharon Sauter; Mark B Ericksen; Patrick Ryan; Amal Assa'ad; Michelle Lierl; Thomas Fischer; Carolyn Kercsmar; Karen McDowell; Anne W Lucky; Anita P Sheth; Andrew D Hershey; Richard M Ruddy; Marc E Rothenberg; Gurjit K Khurana Hershey Journal: Pediatr Allergy Immunol Pulmonol Date: 2012-06 Impact factor: 1.349
Authors: Robert S Tepper; Conrado J Llapur; Marcus H Jones; Christina Tiller; Cathy Coates; Risa Kimmel; Jeffrey Kisling; Barry Katz; Yan Ding; Nancy Swigonski Journal: J Allergy Clin Immunol Date: 2008-08-28 Impact factor: 10.793
Authors: Jayanta Gupta; Elisabet Johansson; Jonathan A Bernstein; Ranajit Chakraborty; Gurjit K Khurana Hershey; Marc E Rothenberg; Tesfaye B Mersha Journal: J Allergy Clin Immunol Date: 2016-06-11 Impact factor: 10.793